Sisram Medical Ltd

SEHK:1696 株式レポート

時価総額:HK$1.5b

Sisram Medical マネジメント

マネジメント 基準チェック /24

Sisram Medicalの CEO はLior Dayanで、 Jun2017年に任命され、 の在任期間は 7.42年です。 の年間総報酬は$ 1.53Mで、 56.6%給与と43.4%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.2%を直接所有しており、その価値はHK$ 2.98M 。経営陣と取締役会の平均在任期間はそれぞれ1.8年と7.3年です。

主要情報

Lior Dayan

最高経営責任者

US$1.5m

報酬総額

CEO給与比率56.6%
CEO在任期間7.4yrs
CEOの所有権0.2%
経営陣の平均在職期間1.8yrs
取締役会の平均在任期間7.3yrs

経営陣の近況

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Jun 17
Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Recent updates

What Sisram Medical Ltd's (HKG:1696) 40% Share Price Gain Is Not Telling You

Oct 07
What Sisram Medical Ltd's (HKG:1696) 40% Share Price Gain Is Not Telling You

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Aug 23
Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Jul 24
Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Jun 17
Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Apr 21
Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Mar 28
Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Mar 05
Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)

Jan 23
Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)

Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?

Dec 29
Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Nov 09
Is Sisram Medical (HKG:1696) Using Too Much Debt?

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Oct 19
Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?

Sep 18
At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?

Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year

Aug 14
Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Jun 16
Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

May 30
Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Apr 19
Is Sisram Medical (HKG:1696) Using Too Much Debt?

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Mar 01
Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Jan 12
Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Dec 21
Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Dec 01
Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Oct 14
Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Sep 28
Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Aug 25
These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Aug 01
Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

May 19
These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

May 03
Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late

Apr 11
If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late

Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital

Mar 17
Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital

Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?

Nov 22
Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?

Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Aug 22
Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital

Jul 27
Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital

Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair

Jun 24
Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair

CEO報酬分析

Sisram Medical の収益と比較して、Lior Dayan の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

US$24m

Mar 31 2024n/an/a

US$28m

Dec 31 2023US$2mUS$863k

US$31m

Sep 30 2023n/an/a

US$35m

Jun 30 2023n/an/a

US$38m

Mar 31 2023n/an/a

US$39m

Dec 31 2022US$3mUS$1m

US$40m

Sep 30 2022n/an/a

US$38m

Jun 30 2022n/an/a

US$35m

Mar 31 2022n/an/a

US$33m

Dec 31 2021US$2mUS$767k

US$31m

Sep 30 2021n/an/a

US$28m

Jun 30 2021n/an/a

US$24m

Mar 31 2021n/an/a

US$19m

Dec 31 2020US$769kUS$596k

US$13m

Sep 30 2020n/an/a

US$13m

Jun 30 2020n/an/a

US$13m

Mar 31 2020n/an/a

US$17m

Dec 31 2019US$759kUS$606k

US$21m

Sep 30 2019n/an/a

US$22m

Jun 30 2019n/an/a

US$24m

Mar 31 2019n/an/a

US$23m

Dec 31 2018US$884kUS$560k

US$22m

Sep 30 2018n/an/a

US$18m

Jun 30 2018n/an/a

US$14m

Mar 31 2018n/an/a

US$12m

Dec 31 2017US$829kUS$361k

US$11m

報酬と市場: Liorの 総報酬 ($USD 1.53M ) は、 Hong Kong市場 ($USD 336.37K ) の同規模の企業の平均を上回っています。

報酬と収益: Liorの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Lior Dayan (54 yo)

7.4yrs

在職期間

US$1,526,000

報酬

Mr. Lior Moshe Dayan has been Chief Executive Officer and Executive Director at Sisram Medical Ltd since June 6, 2017 and its President since 2023 and is responsible for its overall and day-to-day manageme...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Yi Liu
Executive Chairman8.6yrsUS$27.00k0.053%
HK$ 792.5k
Lior Dayan
President7.4yrsUS$1.53m0.20%
HK$ 3.0m
Jiahong Li
Chief Financial Officerless than a yearデータなしデータなし
Ran Ezioni
Chief Operating Officer6.6yrsデータなしデータなし
Doron Yannai
VP of Finance1.8yrsデータなしデータなし
Nikol Lev
Chief Information Officerless than a yearデータなしデータなし
Tal Rosen
Chief Marketing Officer1.8yrsデータなしデータなし
Orit Segal
Chief People Officer1.8yrsデータなしデータなし
Eyal David
President of ROW1.8yrsデータなしデータなし
Itay Meir
EVP of R&D1.8yrsデータなしデータなし
Keith Adams
President NA1.8yrsデータなしデータなし
Qianli Fang
Company Secretary2.8yrsデータなしデータなし

1.8yrs

平均在職期間

51.5yo

平均年齢

経験豊富な経営陣: 1696の経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Yi Liu
Executive Chairman8.6yrsUS$27.00k0.053%
HK$ 792.5k
Lior Dayan
President7.4yrsUS$1.53m0.20%
HK$ 3.0m
Heung Sang Fong
Independent Non-Executive Director7.3yrsUS$32.00kデータなし
Yifang Wu
Non-Executive Director8.1yrsデータなしデータなし
Chi Fung Chan
Independent Non-Executive Director7.3yrsUS$32.00kデータなし
Jenny Chen
Independent Non-Executive Director7.3yrsUS$32.00kデータなし
Kai Yu Liu
Independent Non-Executive Director7.3yrsUS$32.00kデータなし
Rongli Feng
Non-Executive Director4.3yrsデータなしデータなし

7.3yrs

平均在職期間

51.5yo

平均年齢

経験豊富なボード: 1696の 取締役会経験豊富 であると考えられます ( 7.3年の平均在任期間)。